0001209191-18-034777.txt : 20180601 0001209191-18-034777.hdr.sgml : 20180601 20180601172654 ACCESSION NUMBER: 0001209191-18-034777 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180530 FILED AS OF DATE: 20180601 DATE AS OF CHANGE: 20180601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coric Vlad CENTRAL INDEX KEY: 0001704317 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 18876099 MAIL ADDRESS: STREET 1: C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP STREET 2: 234 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 234 CHURCH STREET, SUITE 304 CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 234 CHURCH STREET, SUITE 304 CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-30 0 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001704317 Coric Vlad C/O BIOHAVEN PHARMACEUTICALS, INC. 234 CHURCH STREET NEW HAVEN CT 06510 1 1 0 0 Chief Executive Officer Common Shares 2018-05-30 4 S 0 741 35.00 D 549259 I By The Vladimir Coric Family Trust 2013 Common Shares 2018-05-30 4 S 0 800 35.00 D 549200 I By The Vladimir Coric Marital Trust 2013 Common Shares 2018-05-31 4 S 0 15648 35.01 D 533611 I By The Vladimir Coric Family Trust 2013 Common Shares 2018-05-31 4 S 0 18971 35.01 D 530229 I By The Vladimir Coric Marital Trust 2013 Common Shares 2018-06-01 4 S 0 8611 35.04 D 525000 I By The Vladimir Coric Family Trust 2013 Common Shares 2018-06-01 4 S 0 5229 35.04 D 525000 I By The Vladimir Coric Marital Trust 2013 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 - $35.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 - $35.05, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 - $35.44, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 - $35.13, inclusive. /s/ Darren DeStefano, Attorney-in-fact 2018-06-01